Tuesday, November 3, 2026

Crypto Regulation Showdown: Clarity Act’s 27% Chance of Passing This Year

The Clarity Act's chances of passing in the U.S. Senate have dropped to 27%, with discussions likely postponed until next month.

China’s Biotech Breakthrough: AbbVie Secures 5.6 Billion USD Deal for RC148 at JPM Healthcare Conference

The JP Morgan Healthcare Conference highlights Chinese biotech firms' advancements, major deals, and AI's role in healthcare innovation.

Kim Jong-un’s Historic Appearance with Xi and Putin: What It Means for North Korea’s Diplomacy

Kim Jong-un's attendance at China's Victory Day event symbolizes a potential shift in North Korea's diplomatic stance.

Health

LG Chem’s Vivameglagon Deal Soars to 855 Million USD: What This Means for Rare Obesity Treatment

LG Chem expands its technology export deal for rare obesity treatment Bivamelagon with Rhythm Pharmaceuticals from 305 million USD to 855 million USD.

Galux Secures 7 Billion KRW in Funding: A Game Changer for AI Drug Development in 2026

AI drug development firm Galux has been selected for the Pre-ICON program, receiving up to 7 billion KRW in guarantee support.

Severance Hospital Designated as Emergency Medical Center: What This Means for Critical Care in Seoul

Severance Hospital has begun operations as a regional emergency medical center in northwest Seoul for critical patients and disaster response.

Samsung Biologics Secures 434 Billion KRW CMO Deal: What This Means for the Biopharmaceutical Market

Samsung Biologics signs a 324 million USD contract for biopharmaceutical contract manufacturing with a global pharmaceutical company.

Affordable Weight Loss: How Hanmi’s Eppe Outshines Wegovy and Mounjaro with 53% Lower Initial Costs

The first month's cost of the domestic obesity treatment Eppe is around 129,800 KRW, about 53% lower than Mounjaro.
Latest

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Unlock Premium Sound: LG Sound Suite with Dolby Atmos FlexConnect Launches in Korea

LG Electronics launched the LG Sound Suite, an AI-powered audio system offering immersive sound and personalized experiences for users.

Revolutionary Wearable Blood Flow Measurement: How AI and Heat Sensing Technology Are Changing Healthcare

KAIST developed a wireless wearable blood flow measurement system using AI and thermal sensing, enhancing accuracy in health monitoring.

2026 Breakthrough in Stomach Cancer: How Proximal Gastrectomy Enhances Quality of Life

Professor Kim Hyung-il's study shows proximal gastrectomy's effectiveness for early-stage stomach cancer, enhancing patient quality of life.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Understanding Neurogenic Bladder: Key Treatment Options for Asian Seniors in 2026

Neurogenic bladder affects many elderly patients. Early treatment is crucial to prevent complications. Options include catheterization and medication.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

How Lunit’s AI is Transforming Early Breast Cancer Risk Assessment: Key Findings from ECR 2026

Lunit presents 21 research findings at ECR 2026, showcasing AI's potential in breast cancer risk assessment and screening innovations.

Discover the New Touch Prime Campaign for Ultherapy Prime™: Your Guide to Authentic Medical Aesthetics

Merz Aesthetics Korea launches Touch Prime campaign for Ultherapy Prime™, enhancing product authenticity verification via NFC technology.

APR Expands into Medical Devices: What This Means for Home Beauty Tech in 2026

APR is expanding into medical devices, planning to develop and manufacture products while leveraging its beauty tech expertise.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.